Cargando…
First-in-Human Intravenous Seprehvir in Young Cancer Patients: A Phase 1 Clinical Trial
Seprehvir (HSV1716) is an oncolytic herpes simplex virus-1 (HSV-1) previously demonstrated to be well tolerated in pediatric patients when administered intratumorally. To determine the safety of administering Seprehvir systemically, we conducted the first-in-human phase I trial of intravenous inject...
Autores principales: | Streby, Keri A., Currier, Mark A., Triplet, Melinda, Ott, Kristy, Dishman, Devon J., Vaughan, Michele R., Ranalli, Mark A., Setty, Bhuvana, Skeens, Micah A., Whiteside, Stacy, Yeager, Nicholas D., Haworth, Kellie B., Simpson, Kathleen, Conner, Joe, Cripe, Timothy P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6838937/ https://www.ncbi.nlm.nih.gov/pubmed/31570234 http://dx.doi.org/10.1016/j.ymthe.2019.08.020 |
Ejemplares similares
-
Nothing but NET: A review of norepinephrine transporter expression and efficacy of (131)I-mIBG therapy
por: Streby, Keri A, et al.
Publicado: (2015) -
Immune responses following intrapleural administration of oncolytic SEPREHVIR in patients with malignant pleural mesothelioma
por: Learmonth, Kirsty, et al.
Publicado: (2015) -
Aurora A kinase inhibition enhances oncolytic herpes virotherapy through cytotoxic synergy and innate cellular immune modulation
por: Currier, Mark A., et al.
Publicado: (2017) -
DIPG-11. A PHASE I DOSE ESCALATION STUDY OF BXQ-350 IN CHILDREN AND YOUNG ADULTS WITH RELAPSED SOLID TUMORS
por: Setty, Bhuvana, et al.
Publicado: (2020) -
Pediatric cancer gone viral. Part II: potential clinical application of oncolytic herpes simplex virus-1 in children
por: Friedman, Gregory K, et al.
Publicado: (2015)